Skip to content

EV / EBITDA at other companies

Aramark logo
AramarkARMK
13.4×+1.1×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Addus HomeCare logo
Addus HomeCareADUS
15.8×+0.1×
ALH
Alliance Laundry Holdings Inc.ALH
9.5×
The Ensign Group logo
The Ensign GroupENSG
24.1×+4.4×
Henry Schein logo
Henry ScheinHSIC
12.4×+0.1×

Other financials

Income statement

See full
Revenue$462.8M+3.4%
Gross profit$75.8M+11.6%
Net income$26.1M+51.3%
EPS (diluted)$0.37+60.9%

Balance sheet

See full
Cash & equivalents$136.2M+112%
Total debt$14.7M-11.1%
Total equity$513.8M-0.1%
Total assets$814.8M-1.0%

Cash flow

See full
Operating cash flow$43.7M+59.0%
CapEx$1.4M-19.8%
Free cash flow$42.3M+64.3%

Valuation

See full
Market cap$1.55B+76.0%
Enterprise value$1.43B+70.6%
P/E22.9×+1.6×
P/S0.8×+0.3×

Profitability

See full
Gross margin13.3%0.0pp
Net margin3.7%+1.3pp
FCF margin8.4%

Returns & leverage

See full
Return on equity13.2%+4.8pp
Debt / equity0.0×
Current ratio3.1×+0.2×

Where this comes from

Calculated from Healthcare Services Group’s reported figures.

Based on the most recent quarter.

The official record: Healthcare Services Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Healthcare Services Group's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Healthcare Services Group's EV / EBITDA?
Healthcare Services Group (HCSG) reported EV / EBITDA of 12.2× in Q1 2026.
How has Healthcare Services Group's EV / EBITDA changed year-over-year?
Healthcare Services Group's EV / EBITDA increased by 38.2% year-over-year, from 8.8× to 12.2×.
What is the long-term trend for Healthcare Services Group's EV / EBITDA?
Over 5 years (2020 to 2025), Healthcare Services Group's EV / EBITDA has grown at a 1.0% compound annual growth rate (CAGR), from 13.6× to 14.3×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.